Madeed Raises $400K in Pre-seed Funding

The platform links laboratory results with a practical care plan and ongoing support. January funding supports the first member cohort and a wider clinical and laboratory network.

Round size
$400K
Stage
Pre-seed
Headquarters
Saudi Arabia
Announced
Jan 13, 2026

From a test result to a care plan

Madeed brings diagnostics and follow-up into one membership. A clinician interprets the member’s laboratory results before personalised recommendations are made. Vision Ventures describes the product as a connected loop between testing, medical review and individually formulated daily supplements.

Preparing the first Saudi cohort

The founder’s announcement said early testers had used the service, with a public launch still ahead. The company planned to develop the product and expand its clinical and laboratory partnerships before welcoming its first member cohort in Saudi Arabia.

Where the funding goes

  • Product development
  • Clinical and laboratory partnerships
  • First member cohort in Saudi Arabia

Sources

  1. Madeed: funding announcement
  2. Vision Ventures: direct investment thesis and product explanation
  3. Wamda: dated January financing amount and commercialisation plans
03 / Related rounds

Related funding rounds

01
Series A · Biotech

Engitix

Engitix develops cancer and fibrosis therapies that target the extracellular matrix surrounding cells in diseased tissue.

$25M
02
Series A · Medtech

Luminate Medical

Luminate Medical develops services and devices for home cancer treatment and for reducing chemotherapy side effects.

Led by ARTIS Ventures, Lachy Groom
$21M
03
Pre-seed · Edtech

Sparkli

An AI-based learning platform for children.

$5M